Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 12-2023 | 09-2009 | 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,765 | -13,319 | 1,991,000 | 1,476,000 | 805,000 |
| Depreciation Amortization | 164 | 123 | 929,000 | 582,000 | 296,000 |
| Accounts receivable | -212 | N/A | -179,000 | -303,000 | -292,000 |
| Accounts payable and accrued liabilities | 824 | N/A | N/A | N/A | N/A |
| Other Working Capital | 685 | 112 | -242,000 | -444,000 | -537,000 |
| Other Operating Activity | 3,527 | 806 | 125,000 | 271,000 | 284,000 |
| Operating Cash Flow | $-15,777 | $-12,278 | $2,624,000 | $1,582,000 | $556,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,770 | N/A | -481,000 | -1,406,000 | -703,000 |
| PPE Investments | -1,552 | -217 | -474,000 | -329,000 | -160,000 |
| Net Acquisitions | N/A | 0 | 23,000 | N/A | N/A |
| Other Investing Activity | 0 | -20,269 | -377,000 | 14,000 | 2,000 |
| Investing Cash Flow | $18,218 | $-20,486 | $-1,309,000 | $-1,721,000 | $-861,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -122,000 | -8,000 | -2,000 |
| Debt Repayment | N/A | N/A | -71,000 | -71,000 | -71,000 |
| Common Stock Issued | 42 | N/A | 167,000 | 74,000 | 36,000 |
| Dividend Paid | N/A | 0 | -431,000 | -287,000 | -144,000 |
| Other Financing Activity | 0 | 39,770 | 0 | 0 | 0 |
| Financing Cash Flow | $42 | $39,770 | $-457,000 | $-292,000 | $-181,000 |
| Exchange Rate Effect | N/A | 0 | 81,000 | 47,000 | -42,000 |
| Beginning Cash Position | 15,849 | 8,843 | 3,373,000 | 3,373,000 | 3,373,000 |
| End Cash Position | 18,332 | 15,849 | 4,312,000 | 2,989,000 | 2,845,000 |
| Net Cash Flow | $2,484 | $7,006 | $939,000 | $-384,000 | $-528,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,777 | -12,278 | 2,624,000 | 1,582,000 | 556,000 |
| Capital Expenditure | -1,552 | N/A | -522,000 | -333,000 | -161,000 |
| Free Cash Flow | -17,329 | -12,278 | 2,102,000 | 1,249,000 | 395,000 |